 | |
| Clinical data | |
|---|---|
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.000.534 |
| Chemical and physical data | |
| Formula | C10H20N2O4 |
| Molar mass | 232.280 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Mebutamate (Capla,Dormate) is ananxiolytic andsedativedrug withantihypertensive effects of the carbamate class.[1][2] It has effects comparable to those ofbarbiturates such assecobarbital, but is only around 1/3 the potency of secobarbital as a sedative. Side effects includedizziness andheadaches.[3]
Mebutamate is one of manyGABAergic drugs which act viaallosteric agonism of theGABAA receptor at the β-subreceptor similar to barbiturates. In contrast,benzodiazepines act at the α-subreceptor. As such, carbamates and barbiturates, possessanalgesic properties while the benzodiazepine class of drugs are strictly psychoactive.
Other carbamates with the same mechanism of action and pharmacological properties includemeprobamate,carisoprodol,felbamate, andtybamate.
